Eyepoint Pharmaceuticals Inc (EYPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EYPT | MDXG | VRDN | ||
| Company | Eyepoint Pharmaceuticals Inc | Mimedx Group Inc | Viridian Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 20.30 | 7.65 | 15.08 | ||
| High | 21.25 | 7.75 | 15.50 | ||
| Low | 19.71 | 7.36 | 15.01 | ||
| Last | 19.74 | 7.37 | 15.40 | ||
| Change | -0.20 | -0.13 | +0.82 | ||
| % Change | -1.00% | -1.73% | +5.62% | ||
| Volume | 928,800 | 832,000 | 758,000 | ||
| 20-Day Average Volume | 1,053,040 | 860,890 | 795,720 | ||
| Previous Close | 19.94 | 7.50 | 14.58 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 19.27 | 6.56 | 14.77 | ||
| 20-Day Raw Stochastic | 52.00% | 81.88% | 62.38% | ||
| 20-Day Relative Strength | 47.84% | 55.09% | 47.96% | ||
| Weighted Alpha | -10.12 | +18.68 | -40.69 | ||
| Today's Opinion | 8% Buy | 40% Sell | 72% Sell | ||
| Previous Opinion | 8% Buy | 32% Sell | 88% Sell | ||
| Last Month's Opinion | 24% Buy | 32% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.85% since 04/26/24 | +17.54% since 04/26/24 | +19.57% since 04/26/24 | ||
| Low | 16.36 on 04/29/24 | 6.12 on 04/30/24 | 12.58 on 04/29/24 | ||
| High | 21.25 on 05/03/24 | 7.75 on 05/03/24 | 15.50 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | -4.87% since 04/03/24 | +5.14% since 04/03/24 | -5.29% since 04/03/24 | ||
| Low | 15.51 on 04/25/24 | 5.65 on 04/25/24 | 12.20 on 04/25/24 | ||
| High | 23.65 on 04/12/24 | 7.75 on 05/03/24 | 17.33 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | -31.22% since 02/02/24 | -5.15% since 02/02/24 | -18.30% since 02/02/24 | ||
| Low | 15.51 on 04/25/24 | 5.65 on 04/25/24 | 12.20 on 04/25/24 | ||
| High | 30.99 on 02/08/24 | 9.04 on 02/29/24 | 21.46 on 02/28/24 | ||
| 6-Month | |||||
| %Chg | +154.71% since 11/03/23 | +8.06% since 11/03/23 | +1.38% since 11/03/23 | ||
| Low | 5.86 on 11/22/23 | 5.57 on 11/10/23 | 12.20 on 04/25/24 | ||
| High | 30.99 on 02/08/24 | 9.27 on 12/20/23 | 24.18 on 01/09/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,028,138 | 1,087,842 | 982,859 | ||
| Shares Outstanding, K | 52,084 | 147,604 | 63,822 | ||
| Annual Sales | 46,020,000 | 321,480,000 | 310,000 | ||
| Annual Net Income | -70,800,000 | 58,230,000 | -237,730,000 | ||
| Last Quarter Sales | 14,030,000 | 86,830,000 | 70,000 | ||
| Last Quarter Net Income | -14,100,000 | 53,480,000 | -66,860,000 | ||
| 60-Month Beta | 1.70 | 1.44 | 1.14 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 03/07/24 | 0.07 on 04/30/24 | -1.35 on 02/27/24 | ||
| Latest Earnings Date | 05/01/24 | 04/30/24 | 05/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 46.88 | 0.00 | ||